-+ 0.00%
-+ 0.00%
-+ 0.00%

STRUCTURE THERAPEUTICS REPORTS POSITIVE TOPLINE DATA FROM ACCESS PROGRAM FOR ITS ONCE-DAILY ORAL SMALL MOLECULE GLP-1 RECEPTOR AGONIST, ALENIGLIPRON

Reuters·12/08/2025 13:00:03

Please log in to view news